[go: up one dir, main page]

WO1998004575A3 - Lipophilic oligonucleotide analogs - Google Patents

Lipophilic oligonucleotide analogs Download PDF

Info

Publication number
WO1998004575A3
WO1998004575A3 PCT/US1996/012530 US9612530W WO9804575A3 WO 1998004575 A3 WO1998004575 A3 WO 1998004575A3 US 9612530 W US9612530 W US 9612530W WO 9804575 A3 WO9804575 A3 WO 9804575A3
Authority
WO
WIPO (PCT)
Prior art keywords
lipophilic
oligonucleotide analogs
contain
oligonucleotides
substitutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1996/012530
Other languages
French (fr)
Other versions
WO1998004575A2 (en
Inventor
Norbert W Bischofberger
Kenneth W Kent
Richard W Wagner
Chris A Buhr
Kuei-Ying Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gilead Sciences Inc
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Priority to CA002261704A priority Critical patent/CA2261704A1/en
Priority to PCT/US1996/012530 priority patent/WO1998004575A2/en
Priority to EP96926831A priority patent/EP0923596A2/en
Publication of WO1998004575A2 publication Critical patent/WO1998004575A2/en
Publication of WO1998004575A3 publication Critical patent/WO1998004575A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention discloses lipophilic oligonucleotide analogs that are capable of efficient passive diffusion across cell membranes. These oligonucleotides contain at least two nucleotide residues and have an octanol:water partition coefficient of about -0.3 to + 2.5 and a solubility in water of at least 0.001 νg/mL. Invention embodiments which include lipophilic oligonucleotide analogs having either at least 60 % of the internucleotide linkages are lipophilic, or at least 60 % of the bases contain lipophilic substitutions, or at least 60 % of the sugars contain lipophilic substitutions, or a combination of these sums to 60 %. These oligonucleotides may be conjugated to a label and used to visualize cells or subcellular compartments.
PCT/US1996/012530 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs Ceased WO1998004575A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002261704A CA2261704A1 (en) 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs
PCT/US1996/012530 WO1998004575A2 (en) 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs
EP96926831A EP0923596A2 (en) 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002261704A CA2261704A1 (en) 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs
PCT/US1996/012530 WO1998004575A2 (en) 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs

Publications (2)

Publication Number Publication Date
WO1998004575A2 WO1998004575A2 (en) 1998-02-05
WO1998004575A3 true WO1998004575A3 (en) 1998-03-19

Family

ID=25680807

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/012530 Ceased WO1998004575A2 (en) 1996-07-31 1996-07-31 Lipophilic oligonucleotide analogs

Country Status (3)

Country Link
EP (1) EP0923596A2 (en)
CA (1) CA2261704A1 (en)
WO (1) WO1998004575A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575918B2 (en) 1999-04-14 2009-08-18 The Penn State Research Foundation Tissue-specific and pathogen-specific ribozymes

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2491034A1 (en) 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
KR102231531B1 (en) 2009-02-13 2021-03-23 엑스-켐, 인크. Methods of creating and screening dna-encoded libraries
WO2014187314A1 (en) 2013-05-21 2014-11-27 成都先导药物开发有限公司 Drug target capturing method
ES2954675T3 (en) 2019-01-22 2023-11-23 Vipergen Aps A method of screening an in vitro display library within a cell

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904582A (en) * 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
WO1990010448A2 (en) * 1989-03-07 1990-09-20 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
WO1993010820A1 (en) * 1991-11-26 1993-06-10 Gilead Sciences, Inc. Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
EP0547008A1 (en) * 1991-11-26 1993-06-16 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. New antisense oligonucleotides
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
WO1996029337A1 (en) * 1995-03-23 1996-09-26 Hybridon, Inc. Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
US5633360A (en) * 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484908A (en) 1991-11-26 1996-01-16 Gilead Sciences, Inc. Oligonucleotides containing 5-propynyl pyrimidines

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904582A (en) * 1987-06-11 1990-02-27 Synthetic Genetics Novel amphiphilic nucleic acid conjugates
WO1990010448A2 (en) * 1989-03-07 1990-09-20 Genentech, Inc. Covalent conjugates of lipid and oligonucleotide
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
WO1993010820A1 (en) * 1991-11-26 1993-06-10 Gilead Sciences, Inc. Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
EP0547008A1 (en) * 1991-11-26 1993-06-16 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. New antisense oligonucleotides
US5633360A (en) * 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
WO1996029337A1 (en) * 1995-03-23 1996-09-26 Hybridon, Inc. Thiono triester modified antisense oligodeoxynucleotide phosphorothioates

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J.F.HUGHES ET AL.: "Lipid Membrane Permeability of 2'-Modified Derivatives of Phosphorothioate Oligonucleotides.", JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 83, no. 4, April 1994 (1994-04-01), pages 597 - 600, XP002052615 *
J.M.DAGLE ET AL.: "Physical Properties of Oligonucleotides Containing Phosphoramidate-Modified Internucleoside Linkages.", NUCLEIC ACIDS RESEARCH., vol. 19, no. 8, 1991, OXFORD GB, pages 1805 - 1810, XP002052616 *
S.AKHTAR ET AL.: "Interactions of Antisense DNA Oligonucleotide Analogs with Phospholipid Membranes (Liposomes).", NUCLEIC ACIDS RESEARCH., vol. 19, no. 20, 1991, OXFORD GB, pages 5551 - 5559, XP002052617 *
Z.ZHANG ET AL.: "Thiono Triester Modified Antisense Oligonucleotides for Inhibition of Human Cytomegalovirus in vitro.", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 6, no. 16, August 1996 (1996-08-01), pages 1911 - 1916, XP000677176 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7575918B2 (en) 1999-04-14 2009-08-18 The Penn State Research Foundation Tissue-specific and pathogen-specific ribozymes

Also Published As

Publication number Publication date
CA2261704A1 (en) 1998-02-05
WO1998004575A2 (en) 1998-02-05
EP0923596A2 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
CA2278715A1 (en) Aminooxy-modified oligonucleotides
GB2346908B (en) Electrically sequenced tractor
CA2122030A1 (en) Derivatized Oligonucleotides Having Improved Uptake and Other Properties
ZA973245B (en) Mid-chain branched surfactants.
AUPP123698A0 (en) Self propelling endoscope
EP0981656A4 (en) Low resistivity w using b 2?h 6?
HUP0003384A3 (en) Product comprising at least a double stranded rna combined with at least an antiviral agent
WO2002030421A3 (en) Mediators of hedgehog signaling pathways, compositions and uses related thereto
AU6414699A (en) Vertebral endplate decorticator and osteophyte resector
WO1999004038A3 (en) Biallelic markers for use in constructing a high density disequilibrium map of the human genome
ZA993210B (en) Modular self-service terminal.
WO1998004575A3 (en) Lipophilic oligonucleotide analogs
AU7825898A (en) Light-duty liquid dishwashing detergent compositions which have desirable low temperature stability and desirable greasy soil removal and sudsing characteristics
ZA972248B (en) Flotation cell row
IT1308393B1 (en) SUPPORT FOR BAR (E) WITH HOUSING (S) ABLE TO RECEIVE DIFFERENT CROSS SECTIONS.
GB2378468B (en) Electrically sequenced tractor
ZA989644B (en) Insoluble insulen compositions.
GB9720449D0 (en) Improvements in or relating to connectors
ZA98187B (en) Improvements in or relating to organic compositions.
GB2323976B (en) Improvements in or relating to electrical connectors
GB9825687D0 (en) Oligonucleotide conjugation
EP0615313A3 (en) Improvements in or relating to electrical sockets.
Elliott Winners and losers in the new deregulated telecommunications environment
AU4049397A (en) Radiolabeled o-methyl phosphotriester and o-methyl phosphorothioate internucleoside linkages and oligonucleotides containing the same
EP1033403A4 (en) Gene originating in human fetal chondrocytes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2261704

Country of ref document: CA

Ref country code: CA

Ref document number: 2261704

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996926831

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996926831

Country of ref document: EP